PEVAX Mutual Fund

NAV$20.02

Fund Essentials - as of Apr 30, 2026

Net Assets
$11M
Expense Ratio
1.28%
Dividend Yield (Current)
0.23%
Holdings
182
Inception Date
Nov 27, 2000
Fund Family
UBS Asset Management (Americas) LLC
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+16.62%
1 Year+24.74%
3 Year+11.48%
5 Year+4.44%
10 Year+8.65%

Asset Allocation

Stocks: 100.00%

Price Chart (6M)

Loading chart data...

Top Holdings

View All →
TickerNameWeight
ACLSAxcelis Technologies Inc1.59%
ARWArrow Electronics Inc.1.34%
AVTAvnet Inc0.91%
AVYAvery Dennison Corp.0.88%
FLEX:SIFlex Ltd0.72%
Top 10 Concentration: 8.55%Report Date: Apr 30, 2026
Download all 182 holdings for PEVAX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
0.23%
Frequency
Annually
Latest Distribution
$3.87
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO
See how PEVAX ranks against its peers
Category rank, peer-average returns and outperformance, updated daily.
$49$29/mo
Claim the $29 launch price
First 500 subscribers, then $49/mo. Cancel anytime. From MarketXLS, trusted since 2014.

PEVAX Mutual Fund Overview

PEVAX Mutual Fund (Pace Small/Medium Co Value Equity Investments Fund Class A) is managed by UBS Asset Management (Americas) LLC with $11.4M in net assets. PEVAX expense ratio is 1.28%, holding 182 positions across sectors including Unknown, Information Technology, Financials. Inception date: 2000-11-27.

PEVAX performance shows a YTD return of 16.62%. The 1-year return is 24.74% and the 5-year return is 4.44%. PEVAX dividend yield stands at 0.23%, paid annually.

PEVAX top holdings include Axcelis Technologies Inc (1.6%), Arrow Electronics Inc. (1.3%), Avnet Inc (0.9%), Avery Dennison Corp. (0.9%), Flex Ltd (0.7%). View all PEVAX holdings, sector breakdown, or dividend history.

PEVAX can be compared against other funds using the overlap calculator or side-by-side comparison tool. PEVAX alternatives are available via the screener, along with tax-loss harvesting opportunities.